KLBF:IDX
Kalbe Farma Tbk PT
725,00 IDR
arrow_upward
+0,69%(+5,00) 1D
29. 9., 16:14:45 GMT+7 · IDR
search
Všechny symboly
1D
5D
1M
6M
YTD
1R
5R
MAX
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro KLBF…
Otevřít
725 IDR
Max.
730 IDR
Min.
705 IDR
Trž. kap.
33,94 bil.
Prům. obj.
75,19 mil.
Objem
37,92 mil.
Dividenda
2,76 %
Čtvrtletní dividenda
5 IDR
Datum ex dividenda
4. 6. 2026
Ukazatel P/E
9,11
52týd. max.
1 345 IDR
52týd. min.
630 IDR
EPS
80 IDR
Akcie v oběhu
46,81 mld.
Počet zaměstnanců
13 tis.
Otevřít
725 IDR
Max.
730 IDR
Min.
705 IDR
Trž. kap.
33,94 bil.
Prům. obj.
75,19 mil.
Objem
37,92 mil.
Dividenda
2,76 %
Čtvrtletní dividenda
5 IDR
Datum ex dividenda
4. 6. 2026
Ukazatel P/E
9,11
52týd. max.
1 345 IDR
52týd. min.
630 IDR
EPS
80 IDR
Akcie v oběhu
46,81 mld.
Počet zaměstnanců
13 tis.
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Informace o Kalbe Farma Tbk PT